Editorial: Biology and treatment of high-risk CLL

• Eugen Tausch,
• Jitka Malcikova,
• Jitka Malcikova,
• John C. Riches,
• John C. Riches,
• Jennifer Edelmann

Affiliations

Eugen Tausch

Division of Chronic Lymphocytic Leukemia (CLL), Department of Internal Medicine III, Ulm University, Ulm, Germany

Jitka Malcikova

Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czechia

Jitka Malcikova

Department of Internal Medicine – Hematology and Oncology, University Hospital Brno, Masaryk University, Brno, Czechia

John C. Riches

Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

John C. Riches

Department of Haemato-Oncology, Barts Health NHS Trust, St. Bartholomew’s Hospital, London, United Kingdom

Jennifer Edelmann

Ulm University Hospital, Ulm, Germany